Canada markets open in 2 hours 44 minutes

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.38780.0000 (0.00%)
At close: 09:43AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.31M
Enterprise Value -12.01M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.84
Price/Book (mrq)0.33
Enterprise Value/Revenue -1.93
Enterprise Value/EBITDA 3.42

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-74.34%
S&P500 52-Week Change 3-6.48%
52 Week High 31.5200
52 Week Low 30.3878
50-Day Moving Average 30.4094
200-Day Moving Average 30.6064

Share Statistics

Avg Vol (3 month) 3620
Avg Vol (10 day) 33.31k
Shares Outstanding 516.36M
Implied Shares Outstanding 6N/A
Float 89.81M
% Held by Insiders 137.02%
% Held by Institutions 15.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin -62.52%
Operating Margin (ttm)-100.51%

Management Effectiveness

Return on Assets (ttm)-24.44%
Return on Equity (ttm)-30.38%

Income Statement

Revenue (ttm)6.21M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)8.50%
Gross Profit (ttm)6.07M
Net Income Avi to Common (ttm)-3.88M
Diluted EPS (ttm)-0.2980
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.04M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)1.02M
Total Debt/Equity (mrq)5.34
Current Ratio (mrq)8.06
Book Value Per Share (mrq)1.19

Cash Flow Statement

Operating Cash Flow (ttm)-5.03M
Levered Free Cash Flow (ttm)-3.6M